Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: North America Stem Cell Umbilical Cord Blood Market
Chapter 4. North America Stem Cell Umbilical Cord Blood Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Laboratory Requirements
4.1.2. Processing and Storage
4.1.3. Distribution
4.1.4. End users
4.2. Industry Outlook
4.2.1. Top 10 Cord Blood Banks around the globe
4.2.2. Odds of using Cord Blood Stem Cells
4.2.3. Regulatory environment of cord blood
4.2.4. Top Hematopoietic Stem Cell Therapy Companies
4.2.5. HPSc Gene Therapy for genetic disorder
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2027
4.7.2. Price Trend Analysis
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2020
4.8.3. Competitor Mapping
Chapter 5. North America Stem Cells Umbilical Cord Blood Market Analysis, By Therapeutics
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
5.2.1. Cancer
5.2.2. Diabetes
5.2.3. Blood diseases
5.2.4. Immune disorders
5.2.5. Metabolic disorders
5.2.6. Bone marrow failure syndrome
5.2.7. Other diseases
Chapter 6. North America Stem Cells Umbilical Cord Blood Market Analysis, By Applications
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
6.2.1. Transplant medicine
6.2.2. Regenerative medicine
6.2.3. Hematopoietic stem cell therapy
Chapter 7. North America Stem Cells Umbilical Cord Blood Market Analysis, By Country
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
7.2.1. The U.S.
7.2.2. Canada
7.2.3. Mexico
Chapter 8. The U.S Stem Cells Umbilical Cord Blood Market Analysis
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
8.2.1. By Therapeutics
8.2.2. By Application
Chapter 9. Canada Stem Cells Umbilical Cord Blood Market Analysis
9.1. Key Insights
9.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
9.2.1. By Therapeutics
9.2.2. By Application
Chapter 10. Mexico Stem Cells Umbilical Cord Blood Market Analysis
10.1. Key Insights
10.2. Market Size and Forecast, 2017 - 2027 (US$ Mn)
10.2.1. By Therapeutics
10.2.2. By Application
Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
11.1. Advanced Cell Technology
11.2. Americord Registry Esperite
11.3. Athersys
11.4. California Stem Cell
11.5. CBR Systems, Inc.
11.6. China Cord Blood Corporation
11.7. Cord Blood America
11.8. Cordlife Group Limited
11.9. Cryo-Cell International
11.10. Cryoviva India
11.11. Sangamo Therapeutics
11.12. Esperite
11.13. Excell Thera
11.14. Gemida Cell
11.15. Geron Corporation
11.16. LifeCell Inetrnational
11.17. Medipost
11.18. Megenta Therapeutics
11.19. Mesoblast Limited
11.20. Neostem
11.21. Cryo-Save
11.22. Opexa Therapeutics
11.23. Regrow Biosciences Pvt. Ltd.
11.24. Smart Cells International Ltd.
11.25. Tacitus
11.26. SinoBiological
11.27. Stem cell Technologies
11.28. Teva Pharmaceuticals
11.29. ViaCord
11.30. Vita34 AG
11.31. NextGen
11.32. CSG-BIO
11.33. Fate Therapeutics, Inc.
11.34. Celaid Therapeutics Inc.